Bo Zhu

机构：Army Medical University, Chongqing University, Capital Medical University, Daping Hospital, Xinqiao Hospital, Beijing Friendship Hospital, Chongqing University of Technology, Chongqing Medical University · ORCID：0000-0003-0224-8512

发表论文 97 篇 · 总被引 2089 次 · h-index 23

代表论文

• Impact of lymphadenectomy extent on immunotherapy efficacy in postresectional recurred non-small cell lung cancer: a multi-institutional retrospective cohort study (2023 · International Journal of Surgery · 被引 68)
• Bone metastases diminish extraosseous response to checkpoint blockade immunotherapy through osteopontin-producing osteoclasts (2025 · Cancer Cell · 被引 36)
• Efficacy, safety and exploratory analysis of neoadjuvant tislelizumab (a PD-1 inhibitor) plus nab-paclitaxel followed by epirubicin/cyclophosphamide for triple-negative breast cancer: a phase 2 TREND trial (2025 · Signal Transduction and Targeted Therapy · 被引 19)
• Toripalimab plus chemotherapy for first line treatment of advanced non-small cell lung cancer (CHOICE-01): final OS and biomarker exploration of a randomized, double-blind, phase 3 trial (2024 · Signal Transduction and Targeted Therapy · 被引 16)
• IL-1 signaling in aging and cancer: An inflammaging feedback loop unveiled (2024 · Cancer Cell · 被引 8)
• S100A8/A9 perturbation in bone marrow blunts antitumor immunity by promoting protumorigenic myelopoiesis in mouse models (2025 · Science Translational Medicine · 被引 7)